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perform data normalization and in relevant cases digitally 
remove contrast agent from the bladder.   
Evaluation was performed on CT data from 18 prostate 
cancer patients, each with 7 to 10 repeat CT scans. Manual 
delineations of the prostate, lymph nodes, seminal 
vesicles, bladder and rectum were available for 
evaluation. Geometric performance was quantified using 
the Mean Surface Distance (MSD). The pipeline was 
validated dosimetrically on 11 out of 18 patients by 
simulating an online-adaptive PT workflow based on the 
propagated contours. To this end, for each repeat CT, a 
treatment plan was generated based on the propagated 
contours and the plan was evaluated using the manual 
delineations. A dose of 74 Gy was assigned to the high-
dose PTV (prostate) and 55 Gy to the low-dose PTV (lymph 
nodes and seminal vesicles). The generated treatment 
plans were considered clinically acceptable if dosimetric 
coverage constraints derived from the manual contours 
were met (PTV V95% ≥ 98% and V107% ≤ 2%). 
Results 
The proposed pipeline achieved a MSD of 1.29 ± 0.33, 1.44 
± 0.68, and 1.52 ± 0.45 mm for the prostate, seminal 
vesicles, and lymph nodes, respectively (Fig. 1). The 
propagated contours met the dose coverage constraints in 
85%, 91%, and 99% of the cases for the prostate, seminal 
vesicles, and lymph nodes, respectively (Fig. 2). 78% of 
the cases met all constraints at the same time, compared 
to 65% when using a standard registration approach. The 
average runtime for the proposed pipeline is 98 seconds 
per registration. 
 
 
 
 
 
Conclusion 
The proposed registration pipeline obtained highly 
promising results for generating treatment plans adapted 
to the daily anatomy. With 78% of the automatically 
generated treatment plans directly usable without manual 
correction, a substantial improvement in system 
robustness was reached compared to an existing 
approach. The proposed method therefore facilitates 
more precise PT of prostate cancer. 
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Purpose or Objective 
To investigate the setup errors for pediatric craniospinal 
irradiation (CSI) by following image guided correction 
protocols and explore how daily image-guided 
radiotherapy (IGRT) has impacted the positioning 
uncertainty. In particular, we wish to determine the use 
of six degree of freedom (DoF) couch corrections. 
Positioning uncertainty data may be used to estimate the 
uncertainty budget available for planning target volumes 
and organ-at-risk (OAR) margins, which is essential for the 
safe clinical implementation of hippocampal-sparing CSI 
for pediatric medulloblastoma. Patient alignment and 
setup errors become paramount when attempting to spare 
a critical organ such as the hippocampus during CSI. 
Material and Methods 
In this multicenter study, a total of 14 pediatric patients 
treated with CSI were identified for whom treatment 
records and setup images were available. The setup 
images were registered offline to the reference image 
(digitally reconstructed from their pre-treatment 
computed tomography scan) using the automated tool and 
matching on bony anatomy. A 3 and 6 DoF match was 
performed, respectively, using both translational 
(superior-inferior (SI), anteroposterior (AP) and medial-
lateral (ML)) and rotational (yaw = rotation around the AP 
axis, pitch = rotation around the ML axis and roll = rotation 
around the SI axis) information, ignoring the rotational 
deviation since only the 3 DoF couch shift was used for 
positioning these patients during treatment. 
Results 
The residual errors should only include rotational 
deviation since only translational movement on the couch 
is used. However, rotational errors can affect the 
translational deviation as well (Table 1). When correcting 
the shifts according to a simulated IGRT-protocol, where 
the average of the first two fractions are used to correct 
the coming fractions, the results show large inter-
fractional deviations especially for rotational deviations 
(Figure 1). Translational and rotational random 
uncertainty (RU) and systematic uncertainty (SU) were 
derived as well. If using an IGRT-protocol, such as the 
above mentioned, the translational residual setup error 
can be as high as 2.2 cm for an individual patient during a 
single fraction, and the rotational error as high as 5.4 °. If 
using daily IGRT the maximum setup error was reduced to 
0.8 cm translational and 5.4 ° rotational as well as 0.8 cm 
translational and 2.4 ° rotational setup error for 3 and 6 
DoF couch shifts, respectively. The RU and SU of ML and 
roll worsens when only correcting for the first two 
fractions which further strengthens the indications for 
daily IGRT.   
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Purpose or Objective 
To investigate the setup errors for pediatric craniospinal 
irradiation (CSI) by following image guided correction 
protocols and explore how daily image-guided 
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uncertainty. In particular, we wish to determine the use 
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treated with CSI were identified for whom treatment 
records and setup images were available. The setup 
images were registered offline to the reference image 
(digitally reconstructed from their pre-treatment 
computed tomography scan) using the automated tool and 
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lateral (ML)) and rotational (yaw = rotation around the AP 
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around the SI axis) information, ignoring the rotational 
deviation since only the 3 DoF couch shift was used for 
positioning these patients during treatment. 
Results 
The residual errors should only include rotational 
deviation since only translational movement on the couch 
is used. However, rotational errors can affect the 
translational deviation as well (Table 1). When correcting 
the shifts according to a simulated IGRT-protocol, where 
the average of the first two fractions are used to correct 
the coming fractions, the results show large inter-
fractional deviations especially for rotational deviations 
(Figure 1). Translational and rotational random 
uncertainty (RU) and systematic uncertainty (SU) were 
derived as well. If using an IGRT-protocol, such as the 
above mentioned, the translational residual setup error 
can be as high as 2.2 cm for an individual patient during a 
single fraction, and the rotational error as high as 5.4 °. If 
using daily IGRT the maximum setup error was reduced to 
0.8 cm translational and 5.4 ° rotational as well as 0.8 cm 
translational and 2.4 ° rotational setup error for 3 and 6 
DoF couch shifts, respectively. The RU and SU of ML and 
roll worsens when only correcting for the first two 
fractions which further strengthens the indications for 
daily IGRT.   
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Conclusion 
Daily IGRT is the superior choice for pediatric CSI patients. 
However, following an IGRT-protocol is no insurance for a 
satisfactory alignment when only a 3 DoF couch is applied. 
There are still quite large residual errors some of which 
are the result of multiple isocenters and narrow field 
junctions even if a 6 DoF couch shift would be applied. 
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Purpose or Objective 
At our institution, patients with Locally Advanced 
Pancreatic cancer (LAPC) responding to chemotherapy 
undergo SBRT on the Cyberknife using respiratory tracking 
via fiducial markers. SBRT plans exhibit conformal dose 
distributions with high dose gradients, sculpted to the 
anatomy of the planning CT scan (pCT) to protect the 
surrounding organs-at-risk (OAR). These OARs (stomach, 
duodenum and bowel) are also prone to receive additional 
dose due to daily anatomical variations that can result in 
dose-constraints violations. In our previous work, we 
developed a population-based motion model, which using 
principal component analysis, extracted common 
geometric variation patterns from a cohort of LAPC 
patients. Based on this model, we developed a tool to 
identify which LAPC patients may be at risk of exceeding 
the clinical dose-constraint of V35Gy<1ml due to daily 
anatomical changes, and hence, that may benefit from 
online adaptive strategies. 
Material and Methods 
A total of 130 scans were collected for 35 LAPC patients, 
including the pCT scan and ideally 3 pre-fraction in-room 
CT scans (FxCT). The tool was validated by following a 
leave-one-out approach: each patient was tested on a 
model trained with the variations observed in the 
remaining 34 subjects. For each case, the OAR pCT 
contours were registered non-rigidly to the model, which 
was used to sample N (~5000) random OAR deformations. 
The pCT dose volume was sampled inside each simulated 
organ yielding DVHs for each OAR. Next, we collected 
which percentage of simulated OAR had been detected to 
exceed the clinical dose-constraints on each patient. To 
validate the tool performance against real observed 
variations, simulated violation percentages were 
clustered in four risk groups (low risk-0/3Fx; mid-low risk–
1/3Fx; mid-high risk–2/3Fx; high risk–3/3Fx) according to 
how many fractions exceeded the V35 when original plans 
were rigidly transferred to the FxCT. A threshold on each 
OAR was established by optimizing the discrimination of 
patients with higher risks. 
Results 
Simulated violation percentages clustered per risk group 
are shown on Fig. 1. Pearson correlation coefficients of 
0.5-0.8 were found between simulated risk and observed 
dosimetric changes, depending on the OAR. If all observed 
mid-high and high risk patient groups are combined into a 
high risk category, thresholds at 22, 57, 28% would 
maximally identify patients likely to violate OAR dose-
constraints due to moving tissues for the simulated 
duodenums, stomachs and bowels; with a classification 
accuracy of 94, 71, 97%, respectively. 
 
 
 
Conclusion 
The positive relationship between the simulated 
probability of exceeding OAR dose tolerances and 
clinically observed dose-constraint violations is a 
promising tool to identify a high-risk patient suffering 
from the impact of daily variations. Established thresholds 
suggest patients can be stratified by making optimal use 
of available resources, and can prevent giving extra dose 
to low-risk patients not benefiting from plan adaptation. 
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